Biotech’s New Mantra: Proof Over Promise

Biotech’s New Mantra: Proof Over Promise

Success in biopharma is shifting toward leaner teams, disciplined execution, and go-to-market clarity. Cash efficiency is essential. So are proven modalities: monoclonal antibodies, small molecules, RNA, not the platform excesses of the last cycle. This is what a...